The effect of Platelet rich plasma on pregnancy in patients with repeated implantation failure .
Not Applicable
Recruiting
- Conditions
- Does not apply. Because this study is not about diseases..
- Registration Number
- IRCT20211108052998N1
- Lead Sponsor
- Fasa University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
Satisfaction to enter the study
Age <40 years
Body mass index (BMI) <30 kg / m2
Exclusion Criteria
Existence of any uterine abnormalities (congenital or acquired)
Existence of any uterine abnormalities (congenital or acquired) Uncontrolled hormonal disease ( prolactinemia or thyroid disease) and endometriosis
Blood diseases (hemoglobin <9.0 g / dl and platelet count <100,000 per microliter)
Chromosomal defects in the patient or spouse
Lack of quality blastocysts (Grade A or B according to embryological score) for transmission
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study has only one outcome and the end result is a pregnancy test. At the end of the cycle, pregnancy is determined by laboratory evaluation of serum ß-HCG and the presence of fetal heartbeat on transvaginal ultrasound 2 weeks and 5 weeks after embryo transfer, respectively. Timepoint: evaluation of serum ß-HCG and the presence of fetal heartbeat on transvaginal ultrasound 2 weeks and 5 weeks after embryo transfer. Method of measurement: Transvaginal sonography.
- Secondary Outcome Measures
Name Time Method